Sign in with Google. Opens in new tab
bearish
PCAOB and CSRC‘s Agreement on Audit Terms Could Fail - The Real Test of China ADRs Lies Ahead
Xinyao has highlighted this Insight as a Top Pick
230 Views08 Sep 2022 00:14
China ADRs are only a part of Sino-US game, which shouldn't be looked at alone. It’s hard to reach final agreement. The trend of relisting on HKEX/A-share won't change. Watch out for black swan events
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »- BeiGene (ONC US) - First-Ever Quarterly GAAP Profit Marks Major Milestone
- BeiGene (ONC US) - Strong FY25 guidance issued
- BeOne (ONC US) - Inflection Point Arrives: Operating Breakeven in 2025E
- BeiGene (BGNE US) - Growing Non-GAAP Profit
- BeiGene (BGNE US) - Sales Exceeding Expectations and Achieving Non-GAAP Profitability
Trending Collections
More »Loading
Trending Insights
More »- Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
- Xero (XRO AU): Index Flows Following the Capital Raise
- S&P/ASX Indices: Proposed Methodology Changes & The BIG September Rebalance
- NIFTY200 Momentum30 Index Rebalance: HUGE Turnover and Trade as Financials Shine
- Defence Spending Is Not Stimulative
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
- Simcere Pharmaceutical Group (2096.HK) 22H1 - Gloomy Outlook and Risks in Profits13 Sep 2022
- China Healthcare Weekly(Sep9)-Innovative Device Policy,Commercial Success Definition,Don't Be Fooled11 Sep 2022
- People's Insurance (PICC) (1339.HK) - The Rally (If Any) May Not Last Despite Undervalued08 Sep 2022
- PCAOB and CSRC‘s Agreement on Audit Terms Could Fail - The Real Test of China ADRs Lies Ahead08 Sep 2022
- US-China Decoupling: The Impact on China Healthcare25 Aug 2022
- Taiwan Strait Dispute and China-US Tension: The Impact on China Healthcare09 Aug 2022
- The Impact of HFCAA on China ADR (China Healthcare Companies)16 Mar 2022
x